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Amelogenesis imperfecta (AI) is a heterogeneous group of rare inherited diseases 
presenting with enamel defects. More than 30 genes have been reported to be involved 
in syndromic or non-syndromic AI and new genes are continuously discovered (Smith 
et al., 2017). Whole-exome sequencing was performed in a consanguineous family. The 
affected daughter presented with intra-uterine and postnatal growth retardation, skeletal 
dysplasia, macrocephaly, blue sclerae, and hypoplastic AI. We identified a homozygous 
missense mutation in exon 11 of SLC10A7 (NM_001300842.2: c.908C>T; p.Pro303Leu) 
segregating with the disease phenotype. We found that Slc10a7 transcripts were expressed 
in the epithelium of the developing mouse tooth, bones undergoing ossification, and in 
vertebrae. Our results revealed that SLC10A7 is overexpressed in patient fibroblasts. 
Patient cells display altered intracellular calcium localization suggesting that SLC10A7 
regulates calcium trafficking. Mutations in this gene were previously reported to cause a 
similar syndromic phenotype, but with more severe skeletal defects (Ashikov et al., 2018; 
Dubail et al., 2018). Therefore, phenotypes resulting from a mutation in SLC10A7 can 
vary in severity. However, AI is the key feature indicative of SLC10A7 mutations in patients 
with skeletal dysplasia. Identifying this important phenotype will improve clinical diagnosis 
and patient management.
Keywords: skeletal dysplasia, amelogenesis imperfecta, NGS (next generation sequencing), human, rare diseases
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INTRODUCTION
Skeletal dysplasias are a heterogeneous group of diseases 
affecting bone and cartilage formation resulting in short 
stature. These diseases are associated with shorter long bones 
and abnormal shape and/or size of the skeleton, spine, and 
head and, eventually other anomalies (including neurological, 
cardiac, and respiratory defects). Distinguishing individual 
pathologies in this wide group of diseases is improving thanks 
to advances in genomic technologies and genetic analyses 
(Alanay and Lachman, 2011).
Enamel and bone formation share a common mineralization 
process involving the precipitation of inorganic hydroxyapatite 
nanocrystals within organic matrices to form biological structures 
(Abou Neel et  al., 2016). When fundamental mineralization 
processes are disrupted, skeletal dysplasia-associated syndromes 
can include enamel alterations.
Amelogenesis imperfecta (AI) is a heterogeneous group 
of rare inherited diseases presenting with anomalies in dental 
enamel formation. More than 30 genes are known to be involved 
in AI, and new genes are continuously being discovered 
(Smith et  al., 2017).
Here, we  report the case of a patient with a mutation in 
SLC10A7, a potential calcium transporter, presenting with 
skeletal dysplasia associated with AI. We  identified the first 
SLC10A7 missense mutation occurring at the end of the protein 
(p.Pro303Leu) leading to milder skeletal anomalies compared 
to previously described patients with mutations in this gene 
(Ashikov et  al., 2018; Dubail et  al., 2018).
MATERIALS AND METHODS
Patient
The patient was examined at the Centre de Référence des 
Maladies Rares orales et dentaires (O-Rares), Strasbourg, France 
and at the Centre de Compétence des Maladies Osseuses 
Constitutionnelles (OSCAR) in Strasbourg. The oral phenotype 
was documented using the D[4]/phenodent registry protocol1. 
This clinical study is registered at https://clinicaltrials.gov: 
NCT01746121/NCT02397824 and with the French Ministry of 
Higher Education and Research Bioethics Commission as a 
biological collection “Orodental Manifestations of Rare Diseases” 
DC-2012-1677/DC-2012-1002 and was acknowledged by the 
person protection committee. The parents gave written informed 
consents for the genetic analyses performed on the salivary 
samples both for them and their children in accordance with 
the Declaration of Helsinki. They also gave written consent 
for the publication of this case report and the images of their 
daughter presented in Figure 1.
Electron Microscopy
Teeth were washed, stored in 70% ethanol at 4°C, embedded 
in Epon 812 (Euromedex, France), sectioned, and polished. 
1 www.phenodent.org
Sections were then etched with 20% (w/w) citric acid, dehydrated, 
and analyzed by using an optical numeric microscope (KEYENCE, 
Japan) and a Quanta 250 FEG scanning electron microscope 
(SEM) (FEI Company, the Netherlands). Specimens also 
underwent chemical analysis (see Supplementary Methods).
Whole-Exome Sequencing
Whole-exome sequencing (WES) was performed on the affected 
patient (II.4) and her parents (I.1 and I.2) by Integragen (Evry, 
France, 2014). Exons were captured using SureSelect Human 
All Exon Kits (Agilent, France) with the company’s probe library 
(Agilent Human All Exon v5 + UTR 75 Mb Kit) and sequenced 
with an Illumina HISEQ2000 (Illumina, USA) as paired-end 
75  bp reads, resulting in an average coverage of 80X. The 
sequence reads were then aligned to the reference sequence 
of the human genome (GRCh37) (see Supplementary Methods).
Bioinformatics Analysis
Annotation and ranking of SNV/indel were performed 
by VaRank (Geoffroy et  al., 2015) in combination with the 
Alamut Batch software (Interactive Biosoftware, France) 
(see Supplementary Methods).
Sample Collection and Sanger Sequencing 
and Segregation
Saliva samples from the affected daughter, her unaffected parents, 
and siblings were collected (I.1, I.2, II.4, II.1, II.2, and II.3). 
The amplification of the region of interest (see Supplementary 
Table S1 for primers sequences) was performed on genomic 
DNA template followed by a bidirectional Sanger sequencing 
(see Supplementary Methods).
Multiple Protein Sequences Alignment
The SLC10A7 human last transmembrane domain (TM10) was 
aligned with the SLC10A7 sequence of other species using 
Uniprot website2. The data were then imported and visualized 
with Jalview3 and colored according to the “ClustalX” 
coloring scheme.
In situ Hybridization
Mouse embryos embedding and sectioning, probe synthesis 
and in situ hybridization were performed as previously described 
in Laugel-Haushalter et al., 2012. DIG-labeled antisense riboprobe 
was transcribed in vitro with SP6 RNA polymerase (see 
Supplementary Figure S1 for template sequence). The 
experiments were realized in accordance with the European 
Community Council Directive (86/609/EEC).
Western Blot Analysis
Patient and control primary fibroblasts were grown in DMEM 
(2 mM glutamine, 10% FCS), collected, and lysed in Ripa buffer 
containing protease cocktail inhibitor (Roche 06538282001). 
2 http://www.uniprot.org
3 http://www.jalview.org/
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Proteins obtained were used for Western blot, where SLC10A7 
was detected with a specific monoclonal antibody (Novus 
NBP1-59875), followed by secondary HRP-coupled antibody 
hybridization (NA934V, GE Healthcare). Detection by ECL 
using the ChemiDoc™ Touch (BioRad) imaging system was 
performed. Quantification was performed using the ImageLab 
software (BioRad). SLC10A7 was quantified relative to the total 
amount of protein per lane revealed by TCE (T54801 Sigma) 
UV-labeling of the tryptophan residues, as shown on the stain-
free loading control.
Calcium Localization
The control and patient fibroblasts were grown to 75% confluence 
in six-well plates with sterile coverslips. Cells were then incubated 
with 4  μM Fluo4-AM (Thermo Fisher Scientific, #F14201) in 
DMEM medium (2 mM glutamate, 10% FBS) for 15 or 30 min 
at RT, quickly rinsed with fresh medium without Fluo4, and 
rinsed a second time for 15 or 30  min at RT. Cells were 
mounted directly in PBS and observed on a Zeiss Axio Observer 
D1 fluorescent microscope using a 40X objective.
RESULTS
Patient Phenotype
The investigated patient, a girl, is the consanguineous fourth 
child of an Algerian couple with no reported personal or family 
medical history. She presented with intra-uterine growth retardation 
and short femurs detected during the third trimester of pregnancy. 
The child was born at term with a birth height of 42 cm (<<third 
percentile), a birth weight of 2,890  g (10th percentile), and a 
head circumference of 32.5  cm (10th percentile). Rhizomelia 
and brachydactyly of hands and feet were noticed at birth.
Her growth was regular at −3SD for height, −2.5SD for 
weight, and −1SD for head circumference. Clinical examination 
revealed joint laxity without dislocations, articular limitations 
or pain, and a progressive scoliosis. By age 7, the child measured 
106  cm (−3SD), weighted 18  kg (−2.5SD), and had a head 
circumference of 51  cm (0SD).
Radiographs were undertaken at 3 months (Figures 1Aa,Ad, 
Af,Aj,Al,An), at 4  years (Figures 1Ab,Ae,Ag,Ai,Ak,Am,Ao), 
and at 9  years (Figures 1Ac,Ah,Ap). Advanced carpal 
ossification, brachymetacarpia (Figures 1Af–Ah.), and short 
long bones (Figures 1Ai,Al,Am) were noticed at birth. 
Mesomelia grew more evident with age (Figures 1Af–Ah). 
Tarsal bone ossification was also advanced (Figures 1Aj,Ak). 
Vertebral bodies were initially considered as normal, although 
the latest radiographs showed abnormal expansions or 
ballooning (Figures 1Ad,Ae). Spinal hyperlordosis and scoliosis 
developed over time (Figures 1Aa–Ac). Horizontal acetabulum, 
large femoral necks, large iliac wings, and large clavicles 
were also noticed (Figures  1An–Ap). Neither metaphyseal 
nor epiphyseal anomalies were observed (Figures 1Al,Am). 
Different diagnoses of constitutional bones diseases such as 
achondroplasia and hypochondroplasia suggested Silver-Russell 
syndrome and diastrophic dwarfism, but molecular analyses 
ruled out these syndromes. Array-CGH was also normal (data 
not shown). The child had normal psychomotor development, 
although some learning difficulties were recently noticed.
The patient also presented with facial dysmorphisms, including 
microretrognathia, short neck, short nose, flat face, and blue 
sclerae (Figures 1Ba,Bb,Bd,Be). She had a narrow pharyngeal 
A B
C
FIGURE 1 | (A) X-ray images of the skeletal anomalies at 3 months old (a,d,f,j,l,n), 4 years old (b,e,g,i,k,m,o) and 9 years old (c,h,p). Radiographs of the 
vertebral column showed the progressive scoliosis (a–c) and the ballooning of the vertebrae (d,e). Radiographs of hands and feet (f–h,j,k) displayed a progressive 
carpal and tarsal ossification. The patient also presented with short long bones (i,l,m), a genu valgus (l), and a horizontal acetabulum (n–p). (B) Clinical and 
radiological images of the facial and dental anomalies at 2 years old (a,d,f) and 9 years old (b,c,e,g–i). AI is visible in the clinical intraoral photographs affecting both 
the primary (f) and permanent dentition (g,h). The panoramic radiograph showed no radio-opacity contrast between dentine and enamel (i). (C) Optical numeric 
microscope and scanning electronic microscopy (SEM) of primary teeth. Numeric optical view of a sagittal section of a primary tooth. Dentine appears brighter than 
enamel. Lower central primary incisor (a). SEM micrograph of the thin enamel layer covering the vestibular side of the tooth. A thick layer of calcified calculus is 
present (b). Higher magnification of the thin enamel layer. Pseudo-prismatic structures are evident (arrows) (c). Micrograph of the thin enamel showing an outer 
aprismatic layer (between red arrows) exhibiting incremental lines (white arrow) (d). Enamel-dentinal junction showing typical scallops and unusual non-mineralized 
collagen fibers at the interface (e). Higher magnification of the calculus material capping the tooth. Many entangled calcified filamentous bacteria are observed (f).
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tract, a hypodivergent profile with protruding incisors, and 
biproalveoly to compensate (Figure 1Bc) a lingual dysfunction 
and lip inocclusion.
The child had smaller teeth, incisor infraclusion, and 
severe hypoplastic/hypomineralized amelogenesis imperfecta 
on both the primary and permanent dentitions with colored 
and softer enamel (Figure 1B). On radiographs, there was 
no radio-opacity contrast between hypomineralized enamel 
and dentine (Figure 1Bi).
Initial ENT and ophthalmologic examinations were normal. 
Mild hypermetropia and astigmatism were then noticed in the 
first years of life.
Enamel Shows Quantitative and 
Qualitative Defects
Optical microscopy assessments of sagittal sections of a 
primary naturally exfoliated tooth revealed severe enamel 
hypoplasia (Figure 1Ca). The maximum thickness of enamel 
was observed on the vestibular side of the tooth and reached 
80  μm (around 700  μm in a similar control tooth), and the 
entire tooth was capped by dental calculus. Figure 1Cb shows 
the large thickness of the calculus capping compared to the 
narrow enamel layer. In SEM, the thin enamel exhibited wide 
pseudo-rod patterns (Figure 1Cc). Moreover, electron 
microscopy disclosed a very thin outer layer of aprismatic 
enamel with incremental lines parallel to the surface 
(Figure  1Cd). At the scalloped enamel-dentinal junction, a 
non-mineralized interphase of collagen fibrils was evident 
(Figure 1Ce). At this higher magnification, the individual 
enamel crystals could be  observed. Microscopy observations 
of the calculus capping clearly showed calcified bacterial 
structures (Figure 1Cf). When analyzed by energy dispersive 
X-ray spectroscopy (EDX), the calculus material had a Ca/P 
ratio of 1.56  ±  0.04 (n  =  12) (Supplementary Figure S2A). 
Comparatively, EDX measurements were, respectively, 
1.74  ±  0.068 (n  =  15) and 1.64  ±  0.062 (n  =  15) for enamel 
and dentine tissues (Supplementary Figure S2B). Although 
both spectra looked similar, the carbon content was higher 
in dental calculus, i.e., C  =  15.4  ±  0.85 (wt.%) and 
C = 5.13 ± 0.93 (wt.%) for enamel (Supplementary Figure S2).
Mutation in SLC10A7 Associated With 
Syndromic Amelogenesis Imperfecta
Whole-exome sequencing was performed on the index case 
and her parents. By using stringent criteria, identifying 
variants consistent with autosomal recessive disease 
inheritance (Supplementary Table S2), by manual curation 
(Supplementary Table S3), and by Sanger sequencing 
(Supplementary Figure S3, Figure 2A), we  validated the 
homozygous mutation in exon 11 of SLC10A7, a gene involved 
in a novel type of skeletal dysplasia associated with short 
stature, AI, and scoliosis (SSASKS, #OMIM618363) (Ashikov 
et  al., 2018; Dubail et  al., 2018). The mutation leading to 
an amino acid change from proline to leucine in exon 11 
at position 303 (NM_001300842.2:c.908C>T, p.Pro303Leu) 
was absent from databases (1,000 genomes, GnomAD).
The mutation affected the last transmembrane domain (TM10) 
of the SLC10A7 protein. The alignment of this domain sequence 
with sequences of other species showed that the sequence was 
largely conserved between species, with the mutated proline 
(Pro303) being highly conserved (Figure 2B). The mutation was 
also predicted to be  disease causing by SIFT (Vaser et  al., 2016) 
and deleterious by Polyphen2 (Polymorphism Phenotyping v2) 
(PPH2) (Adzhubei et  al., 2010). Collectively, these findings 
suggest an important function for this amino acid.
Expression Pattern of SLC10A7 in 
Developing Mouse Bone and Tooth
The expression of Slc10a7 at E14.5 mouse tooth cap stage had 
been reported in our previous transcriptomic study showing that 
the gene was expressed at similar levels in both molars and 
incisors (Supplementary Table S4; Laugel-Haushalter et al., 2012).
To gain insight into Slc10a7 gene expression during bone 
and tooth development in mice, we  performed an in situ 
hybridization analysis on mouse fetuses. Slc10a7 positive signals 
were observed in the epithelial compartment of E14.5 cap 
stage teeth (Figures 3Aa,Ab). At E16.5, the transcripts were 
mostly localized in the inner dental epithelium and in the 
epithelial loop of the bell stage teeth. A discrete expression 
was also detected in the outer dental epithelium. At E18.5 
labeling was observed in the inner dental epithelium of incisors 
and in ameloblasts and odontoblasts of molars. Slc10a7 expression 
was investigated in developing bones, and mRNA transcripts 
were detected in bones undergoing ossification and vertebrae. 
We  detected an expression not only in vertebrae at E16.5 
(Figures 3Ac,Ad) and E18.5 (Figures 3Ak,Al) but also in the 
E16.5 humerus (Figure 3Ag) and femur (Figure 3Ah).
SLC10A7 Is Overexpressed in Patient 
Fibroblasts
The SLC10A7 protein was identified by western blot analysis 
in protein extracts from patient and unaffected control primary 
skin fibroblasts (Figure 3B). Quantifications were done in 
three independent experiments using total protein extract (as 
revealed by the stain-free labeling) as loading control. The 
level of SLC10A7 protein was approximately two times higher 
in the patient’s cells compared to the unaffected control 
individual cells (Figure 3B). The results shown here were 
further validated using two different SLC10A7 commercial 
antibodies (data not shown).
Abnormal Distribution of Cellular Calcium 
in Patient Fibroblasts
As the SLC10A7 yeast Saccharomyces cerevisiae homologue 
(termed RCH1) is involved in the regulation of a calcium 
transporter (Zhao et  al., 2016), this prompted us to investigate 
the distribution of calcium in patient’s and control fibroblasts. 
Calcium labeling with a Fluo4 probe showed no difference 
in  localization after 15  min of staining (Figure 3C). However, 
after 30  min, while the probe was mainly localized within the 
cytoplasm in the control cells, it was mostly retained within 
the nucleus in the patient’s fibroblasts. This suggests that 
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SLC10A7 could be  involved in calcium transport and that the 
mutation of the patient resulting in an increased level of protein 
interferes with this function (Figure 3C).
DISCUSSION
Human Mutations
The study by (Dubail et  al., 2018) described six patients with 
homozygous mutations in the SLC10A7 gene presenting with 
SSASKS (#OMIM618363). Two patients had splice mutations 
in intron 9 c.774-G>A, c.773+1G>A; two had missense mutations 
c.221T>C and c.388G>A; and two showed the same stop mutation 
c.514C>T. Ashikov et  al., 2018 reported two siblings patients 
with a SLC10A7 compound heterozygous mutation c.335G>A 
and c.722–16A>G and two patients with the same clinical 
presentation with no SLC10A7 cDNA-identified mutations. In 
this paper, we  report a homozygous missense mutation in exon 
11, the only missense mutation reported to date at the end of 
this protein. The location near the end of the protein could 
potentially explain the milder phenotype in our patient (Figure 2C).
The patients described by (Dubail et  al., 2018) displayed a 
more severe phenotype with multiple joint dislocations 
and had clinical features resembling Desbuquois syndrome 
(OMIM#251450, #615777 caused by mutations in CANT1 and 
XYLT1 genes), a chondrodysplasia with defects in GAG biosynthesis. 
The only distinguishable feature between those patients and 
Desbuquois-like patients was the AI phenotype (Table 1). 
A B
C
FIGURE 2 | (A) Analysis of the SLC10A7 mutation: Pedigree of the AI patient and DNA sequencing chromatograms of the whole family. Parents and other children 
were heterozygous and the patient was homozygous for the mutation. An arrow points to the mutation. (B) Multiple sequence alignment of SLC10A7 last 
transmembrane domain (TM10). The largely conserved sequence of the proteins last transmembrane domain is represented by the dark bar. The amino-acid 
affected by the missense mutation in the patient (red square) is conserved from human to yeast. (C) Human SLC10A7 mutations in the literature. The SLC10A7 
gene contains 12 exons. The mutations described in Dubail et al. (2018) are represented by blue arrows and those reported in Ashikov et al., 2018 by red arrows. 
Our mutation is the only mutation located at the end of the gene (exon 11) and is represented by a green arrow.
A B
C
FIGURE 3 | (A) Analysis of mouse Slc10a7 transcripts distribution by in situ hybridization. Sections illustrate Slc10a7 expression in the developing bone, vertebrae, 
molars, and incisors. Developmental stages and section planes are: E14.5 frontal (a,b), E16.5 sagittal (c–h); E18.5 sagittal (i–l) sections. Am, ameloblasts;  
DP, dental papila; EL, epithelial loop; GUB, gubernaculum; IDE, inner dental epithelium; LI, lower incisor; Od, odontoblasts; ODE, outer dental epithelium;  
SR, stellate reticulum; Ve, vertebrae. Scale bars: 10 μm (b); 40 μm (a,c,g,h); 30 μm (d,l); 60 μm (i,j); 80 μm (e,f); 150 μm (k). (B) SLC10A7 expression in control and 
patient skin fibroblasts as detected by western blot. The stain-free membrane, displaying the total amount of protein loaded, was used for quantification.  
The western blot shown corresponds to one significant experiment (n = 3). The data plotted were the mean of three independent experiments. Statistical analysis was 
done with the t-test and the p was determined *p < 0.05. (C) Calcium localization in control and patient fibroblasts. The cells were stained for 15 min or 30 min with 
4 μm of Fluo4, then washed for 15 or 30 min, respectively and observed by fluorescent microscopy. Images were taken with a 400× magnification, scale bar 10 μm.
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In the study by Ashikov et  al., 2018, patients were believed 
similar to Desbuquois syndrome, sharing some intellectual disability 
traits not observed in our patient. However, Ashikov et  al., 2018 
patients also presented AI, a feature not reported so far in 
Desbuquois syndrome (Table  1). Comparing our patient to 
Desbuquois dysplasia patients, growth retardation was less severe 
(−3SD compare to −4 to −10SD). The patient also did not present 
with multiple dislocations or characteristic features like accessory 
ossification centers distal to the second metacarpal, bifid distal 
phalanx, or delta phalanx of the thumb. However, our patient 
had a similar facial appearance–round face, microretrognathism, 
blue sclerae, prominent eyes, and a short neck. Like other reported 
patients, our proband presented with AI. Since classical Desbuquois 
syndrome patients do not present this phenotype, AI may be  a 
key symptom to distinguish SLC10A7-related disorders from 
other chondrodysplasias.
Mutant Mice and SLC10A7  
Expression Pattern
Slc10a7−/− null mice exhibited a dysmorphic face, moderate 
skeletal dysplasia, ligamentous laxity, a reduced bone mass 
(Dubail et  al., 2018) and they were smaller with shorter limbs 
(Brommage et al., 2014). In the mouse incisors, the most external 
layer, the aprismatic enamel layer, was missing, and numerous 
areas of hypoplasia were observed in the external prismatic 
enamel layer (Brommage et  al., 2014; Dubail et  al., 2018). As 
they mimic many clinical features of the patient phenotype, 
they provide a good model to study the physio-pathological 
mechanisms of the syndrome. It is interesting to note that no 
joint dislocations were observed, suggesting that Slc10a7−/− mice 
are mimicking the milder phenotype observed in our patient 
and in previous studies (Brommage et  al., 2014). Here, we  also 
showed that the expression pattern of Slc10a7 in mice was 
consistent with the organs affected in all the described patients. 
Indeed, the gene was expressed in vertebrae, bones undergoing 
ossification and in the epithelial part of the tooth. Those findings 
are supporting the fact that even if the phenotype of SSAKS 
patients can vary in severity and include extra clinical features, 
short stature, scoliosis, and AI are recurrent features to identify 
patients with mutation in SLC10A7.
Role of SLC10A7 in Calcium Transport
Here, we  show that the level of SLC10A7 protein is two times 
higher in affected patient skin fibroblasts compared to controls. 
Moreover, incubation of patient cells with a fluorescent calcium 
probe (Fluo4) led to its accumulation into the nucleus (cytoplasmic 
localization observed in control cells). This suggests that SLC10A7 
may play a role in calcium homeostasis, as reported for the 
SLC10A7 yeast homologue Rch1 (Jiang et  al., 2012). Indeed, 
in yeast, Rch1 is expressed in response to increased calcium 
levels and acts as a negative regulator of calcium uptake by 
binding to a calcium transporter at the plasma membrane (Jiang 
et  al., 2012). Based on these yeast results, SLC10A7 may also 
be  involved in calcium homeostasis, and the patient missense 
mutations could alter this function, potentially leading to calcium 
accumulation in the nucleus of patient fibroblasts and higher 
expression of SLC10A7 to compensate for this defect.
Previous studies concluded that defects in calcium 
uptake led to defects in GAG synthesis explaining SLC10A7 
phenotypes. This mechanism could also produce skeletal defects. 
TABLE 1 | Review of the literature of SLC10A7 patients and clinical comparison with Desbuquois syndrome.
Clinical features Reported patients  
(Dubail et al., 2018)
Reported patients  
(Ashikov et al., 2018)
Our patient Desbuquois syndrome
Intra-uterine growth retardation 6/6 + +
Postnatal growth retardation 6/6 5/5 + (−3SD) + (−4SD to −10SD)
Micrognathia 6/6 2/5 + +
Congenital multiple dislocations 6/6 – − +
Amelogenesis imperfecta 6/6 5/5 + −
Advanced carpal ossification 6/6 + +
Scoliosis 6/6 5/5 + +
Blue sclerae + +
Prominent eyes + + +
Flat face + +
Short neck + + +
Presence of hand anomalies, 
namely, accessory ossification 
center distal to the second 
metacarpal, bifid distal phalanx,  
or delta phalanx of the thumb
− – + (type 1)
Brachydactyly + + +
Short long bones with  
“Swedish key” appearance of  
the proximal femur
4/6 +
Organ malformations – +/−
Mental retardation 4/5 – +/−
The patients from Dubail et al. (2018) presented with a phenotype close to the Desbuquois syndrome phenotype. Patient from (Ashikov et al., 2018) and our proband did not present 
joint dislocation. All the patients were affected by a skeletal dysplasia associated with AI.
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Dental defects, though, could be  due to a small misregulation 
in calcium homeostasis, sufficient to induce enamel defects. 
Moreover, as discussed in Dubail et  al., 2018, some mutations 
in calcium channels and transporters/exchangers (STIM1, ORAI1, 
SLC24A4, SLC24A5, WDR72) (El-Sayed et  al., 2009; Feske, 
2010; Duan, 2014; Wang et  al., 2014) lead to AI without any 
associated GAG biosynthesis defects.
Amelogenesis Imperfecta as a Key  
Clinical Feature in Delineation of  
Skeletal Dysplasia
Skeletal dysplasias are a large, diverse group of diseases in 
which recent progress in genetics has allowed identification 
of many causative genes. An accurate clinical examination can 
also provide key diagnostic clues. Here, we  report the case of 
a patient with a skeletal dysplasia associated with AI. Skeletal 
dysplasia with associated SLC10A7 mutations varies in severity 
and clinical features (Ashikov et  al., 2018; Dubail et  al., 2018) 
but AI is always present. Indeed, mutation in SLC10A7 was 
recently associated to a novel type of skeletal dysplasia with 
short stature, AI, and scoliosis (#OMIM611459). To date, 
combined skeletal dysplasia/AI-associated syndromes have been 
observed in non-lethal Raine syndrome with mutations in 
FAM20C (OMIM#259775) (Elalaoui et  al., 2016), brachyolmia 
with AI caused by mutations in LTBP3 (Huckert et  al., 2015), 
tricho-dento-osseus syndrome caused by mutations in DLX3 
(OMIM#190320) (Nieminen et al., 2011), and congenital disorder 
of glycosylation, type IIk caused by mutations in TMEM165 
(OMIM #614727).
As the association of the two clinical features seems to 
be  rare, this suggests that AI is the key factor pointing to a 
mutation in SLC10A7 in patients presenting with skeletal 
dysplasia and scoliosis. Moreover, comparing our patient to 
those in the literature (Ashikov et  al., 2018; Dubail et  al., 
2018), we  noticed that the skeletal phenotype was milder, 
suggesting that some patients could be  difficult to diagnose. 
Thus, the finding of AI can help improving patient diagnosis.
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